Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-0.18
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.31
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
70.00%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
4.17
EV to EBIT
7.51
EV to EBITDA
6.85
EV to Capital Employed
10.52
EV to Sales
3.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
140.00%
ROE (Latest)
43.33%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
10What is working for the Company
PRE-TAX PROFIT(Q)
At HKD 369.82 MM has Grown at 302.16%
NET PROFIT(Q)
At HKD 374.68 MM has Grown at 308.69%
NET SALES(HY)
Higher at HKD 657.38 MM
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Qyuns Therapeutics Co., Ltd.
Pre-Tax Profit
At HKD 369.82 MM has Grown at 302.16%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 374.68 MM has Grown at 308.69%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Net Sales
Higher at HKD 657.38 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (HKD MM)






